Skip to main content

EDITORIAL article

Front. Cardiovasc. Med., 27 September 2023
Sec. Cardiovascular Surgery
This article is part of the Research Topic Minimally Invasive Cardiac Surgery: State of the art and current challenges View all 10 articles

Editorial: Minimally invasive cardiac surgery: state of the art and current challenges

  • 1Department of Cardiovascular Surgery, Goethe University and University Hospital Frankfurt, Frankfurt/Main, Germany
  • 2Department of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway
  • 3Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria

Editorial on the Research Topic
Minimally invasive cardiac surgery: State of the art and current challenges

Minimally invasive cardiac surgery (MICS) has undergone a rapid evolution over the past three decades due to the significant progress in the development of emerging technologies and improved surgical techniques in the cardiovascular field.

Only about one-third of all cardiac surgery procedures are currently performed via small skin incisions (minithoracotomy and ministernotomy). However, the invasiveness of any cardiosurgical procedure cannot only be defined by access (skin incision) but also by the use of cardiopulmonary bypass with potential cardiac arrest and heart valve repair or valve-sparing operation (1). This positive trend continues to evolve, notably with the development of increasingly efficient endoscopic, robotic, and transcatheter procedures (24).

Driven by reduced surgical trauma, blood loss, pain, and hospital stay, as well as better cosmesis and quality of life, the considerable attention gained through the application of MICS is attributable to improved postoperative outcomes (58). However, some concerns remain with the technical challenges and the consequent prolonged intraoperative durations and risks of vascular complications, including thromboembolism, as well as associated neurological complications (9).

With this Research Topic, we aim to provide readers, clinicians, researchers, and developers a broad scientific and technological overview of the progress made with the various innovative minimally invasive surgical, reconstructive, and interventional approaches to coronary arteries, heart valves, and aortas, since their introduction about 30 years ago.

An excellent didactic summary of 10 years of experience with MICS, especially endoscopic, incorporating seven lessons learned is provided by Ahmad et al. Based on their broad experience, the authors suggest MICS can be safely, effectively, and reproducibly performed by a wide range of surgeons. Additionally, it can serve as a good template for establishing MICS and accelerating the learning curve while improving patient outcomes. From the same two institutions, an interesting overview about the experience with minimally invasive direct coronary artery bypass grafting (MIDCAB) is published by Monsefi et al.. The authors present the short-term results of 234 patients undergoing MIDCAB between 2017 and 2021 with a 30-day mortality of 1.7%. This study confirms the aforementioned fact that the recently started MICS programme can offer very good outcomes to patients. These short-term results are even comparable with the largest ever published MIDCAB cohort (10).

The gold standard treatment of primary degenerative mitral valve insufficiency is surgical valve repair, which nowadays is performed predominantly in MICS and increasingly in three-dimensional endoscopic fashion (2). Elderly patients suffering from additional atherosclerosis bear an increased risk due to retrograde arterial perfusion. Selective cannulation of the right axillary artery and herewith antegrade perfusion may be of benefit. Petersen et al. performed a study comparing short-term outcomes of this perfusion strategy with standard retrograde femoral perfusion. They conclude that patients with a higher perioperative risk and severe atherosclerosis would benefit from antegrade axillary perfusion.

Since its introduction in 1992, aortic valve (AV) reimplantation (David procedure) has become the standard technique for patients suffering from aortic root aneurysm with or without AV insufficiency and has produced excellent short- and long-term results (11). A quarter century experience with this valve-sparing operation from a teaching centre is reported by Sromicki et al. The 30-day mortality of their cohort of 131 patients was 2%. Freedom from reoperation at 5 and 10 years was 93.5% ± 2.4% and 87.0% ± 3.5%, respectively. These results are comparable with other mid-volume centres (12); however, they are not as exceptional as the results from the Toronto group. In our opinion, the explanation for these exceptional and almost unreproducible results is the extreme selection of patients over the increasing course of time.

Adding a minimal access to the aortic valve-sparing, this procedure can be then considered as a great representative of MICS and is of major benefit to the patients. Shrestha et al. compared patients undergoing elective isolated David procedure via ministernotomy (42 patients) with full sternotomy (220 patients). Despite the fact that perioperative outcomes (cardio-pulmonary bypass and aortic cross-clamp time) were statistically relevantly shorter in the full sternotomy group, no difference was found in short- and long-term postoperative outcomes, including valve performance.

The MICS has not yet been adopted in aortic arch repair and even less in the surgery of acute type A aortic dissection (13). Since January 2019, Xie et al. have operated all obese (BMI ≥30 kg/m2) patients with acute type A aortic dissection using a self-made triple-branched stent-graft for total arch replacement via partial upper sternotomy. In their study, 35 patients underwent full sternotomy, and 30 partial upper sternotomy. The latter strategy was proved to be safe, effective, and superior to full sternotomy in terms of blood loss, postoperative blood transfusion, and respiratory complications.

The Research Topic was rounded off by three interesting case reports. Pojar et al. present a remarkable case of successful robotic repair of unroofed coronary sinus, which was accomplished using an excellent high-resolution video. Salamate et al. publish an extraordinary technically challenging case of video-assisted minimally invasive mitral and pulmonary valve replacement as a reoperation in a patient with situs invs. totalis. This case report was also accomplished using an excellent high-resolution video. Finally, Wu et al. present a remarkable case of successful minimally invasive bicuspid AV repair through right-anterior minithoracotomy.

The aim of this Research Topic was to assess current progress in MICS of the coronary arteries, heart valves, and aorta. Nine papers were accepted and collected in this Research Topic, and to date, have been seen by over 7,500 readers. These publications confirm the steady progress of this approach and demonstrate that MICS is safe and feasible. However, MICS is still relatively uncommon, being confined mainly to specialist centres. In our opinion, MICS is the approach of the future and is a priori suitable for every patient and every pathology; nevertheless, precise selection and rigorous preoperative planning are essential. More in-depth analyses on larger groups are also required.

Author contributions

TH: Conceptualization, Methodology, Writing – original draft, Writing – review & editing. GD: Methodology, Writing – original draft, Writing – review & editing. NB: Methodology, Writing – original draft, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Holubec T, Salem R, Walther T. What exactly is minimally invasive? Ann Thorac Surg. (2023) 115(5):1325. doi: 10.1016/j.athoracsur.2022.06.005

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Van Praet KM, Stamm C, Sündermann SH, Meyer A, Unbehaun A, Montagner M, et al. Minimally invasive surgical mitral valve repair: state of the art review. Interv Cardiol. (2018) 13(1):14–9. doi: 10.15420/icr.2017:30:1

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Cerny S, Oosterlinck W, Onan B, Singh S, Segers P, Bolcal C, et al. Robotic cardiac surgery in Europe: status 2020. Front Cardiovasc Med. (2021) 8:827515. doi: 10.3389/fcvm.2021.827515

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Walther C, Fichtlscherer S, Holubec T, Vasa-Nicotera M, Arsalan M, Walther T. New developments in transcatheter therapy of mitral valve disease. J Thorac Dis. (2020) 12(4):1728–39. doi: 10.21037/jtd.2019.12.137

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Bonacchi M, Prifti E, Giunti G, Frati G, Sani G. Does ministernotomy improve postoperative outcome in aortic valve operation? A prospective randomized study. Ann Thorac Surg (2002) 73(2):460–5; discussion 5–6. doi: 10.1016/s0003-4975(01)03402-6

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Bakir I, Casselman FP, Wellens F, Jeanmart H, De Geest R, Degrieck I, et al. Minimally invasive versus standard approach aortic valve replacement: a study in 506 patients. Ann Thorac Surg. (2006) 81(5):1599–604. doi: 10.1016/j.athoracsur.2005.12.011

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Woo YJ, Seeburger J, Mohr FW. Minimally invasive valve surgery. Semin Thorac Cardiovasc Surg. (2007) 19(4):289–98. doi: 10.1053/j.semtcvs.2007.10.005

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Sündermann SH, Sromicki J, Rodriguez Cetina Biefer H, Seifert B, Holubec T, Falk V, et al. Mitral valve surgery: right lateral minithoracotomy or sternotomy? A systematic review and meta-analysis. J Thorac Cardiovasc Surg. (2014) 148(5):1989–95.e4. doi: 10.1016/j.jtcvs.2014.01.046

CrossRef Full Text | Google Scholar

9. Falk V, Cheng DC, Martin J, Diegeler A, Folliguet TA, Nifong LW, et al. Minimally invasive versus open mitral valve surgery: a consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010. Innovations (Phila). (2011) 6(2):66–76. doi: 10.1097/IMI.0b013e318216be5c

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Davierwala PM, Verevkin A, Bergien L, von Aspern K, Deo SV, Misfeld M, et al. Twenty-year outcomes of minimally invasive direct coronary artery bypass surgery: the Leipzig experience. J Thorac Cardiovasc Surg. (2023) 165(1):115–27.e4. doi: 10.1016/j.jtcvs.2020.12.149

PubMed Abstract | CrossRef Full Text | Google Scholar

11. David TE, David CM, Ouzounian M, Feindel CM, Lafreniere-Roula M. A progress report on reimplantation of the aortic valve. J Thorac Cardiovasc Surg. (2021) 161(3):890–9.e1. doi: 10.1016/j.jtcvs.2020.07.121

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Tamer S, Mastrobuoni S, Lemaire G, Jahanyar J, Navarra E, Poncelet A, et al. Two decades of valve-sparing root reimplantation in tricuspid aortic valve: impact of aortic regurgitation and cusp repair. Eur J Cardiothorac Surg. (2021) 59(5):1069–76. doi: 10.1093/ejcts/ezaa427

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Risteski P, El-Sayed Ahmad A, Monsefi N, Papadopoulos N, Radacki I, Herrmann E, et al. Minimally invasive aortic arch surgery: early and late outcomes. Int J Surg. (2017) 45:113–7. doi: 10.1016/j.ijsu.2017.07.105

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: minimally invasive cardiac surgery (MICS), coronary revascularization (MIDCAB and OPCAB), hybrid coronary revascularization, valve surgery, aortic surgery, endoscopic and robotic cardiac surgery

Citation: Holubec T, Dahle G and Bonaros N (2023) Editorial: Minimally invasive cardiac surgery: state of the art and current challenges. Front. Cardiovasc. Med. 10:1286868. doi: 10.3389/fcvm.2023.1286868

Received: 31 August 2023; Accepted: 12 September 2023;
Published: 27 September 2023.

Edited and Reviewed by: Hendrik Tevaearai Stahel, University Hospital of Bern, Switzerland

© 2023 Holubec, Dahle and Bonaros. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tomas Holubec tomas.holubec@kgu.de; tomasholubec@email.cz

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.